Td Private Client Wealth LLC Corcept Therapeutics Inc Transaction History

Td Private Client Wealth LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 16, 2024	SELL	$19.2 - $24.47 $11,424 - $14,559	-595 Closed	0 $0
Q4 2022 Aug 16, 2024	SELL	$19.95 - $29.96 $498 - $749	-25 Reduced 4.03%	595 $12.1 Million
Q3 2022 Aug 16, 2024	SELL	$24.7 - $29.12 $469 - $553	-19 Reduced 2.97%	620 $15.9 Million
Q2 2022 Aug 16, 2024	SELL	$17.33 - $25.3 $1,195 - $1,745	-69 Reduced 9.75%	639 $15.2 Million
Q1 2022 Aug 16, 2024	BUY	$16.53 - $25.21 $11,703 - $17,848	708 New	708 $15.9 Million

311

88.3M

1.07M

973K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $4.53B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Td Private Client Wealth LLC with notifications on news.